Bizarre Patents
User-operated amusement apparatus for kicking the user's buttocks
An apparatus including a user-operated and controlled apparatus for self-infliction of repetitive blows to the user's buttocks by a plurality of elongated arms bearing flexible extensions that rotate under the user's control.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5209933 | Long acting calcium channel blocker composition There is disclosed an improved long acting sustained release pharmaceutical composition for dihydropyridine calcium channel blockers wherein the calcium channel blocker and a pH-dependent binder, which are intimately admixed in essentially spherically sha... | 05/11/1993 |
| 5208036 | N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R1 and R2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R3, R4 and R | 05/04/1993 |
| 5177072 | Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives Heterocyclic aminoalkyl esters of mycophenolic acid, and the derivatives and pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, anti-inflammatory agents, anti-tumor agents, anti-viral agents, and anti-psoriatic agents.... | 01/05/1993 |
| 5164405 | Nicardipine pharmaceutical composition for parenteral administration There is disclosed a stable pharmaceutical composition containing nicardipine hydrochloride, a non-chloride isotonicity agent, a buffering agent and a pharmaceutically acceptable aqueous vehicle for parenteral administration.... | 11/17/1992 |
| 5142052 | Cationic effect-driven carbinol/amine reaction Aryl- and heterocyclic-methanamines are prepared by reacting a hydroxy-aryl carbinol or a heterocyclic carbinol with a primary or a secondary amine in the presence of a cationic effect reagent.... | 08/25/1992 |
| 5091428 | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein: R1 is aryl, lower alkyl, cycloalkyl or hydrogen; R2 is aryl, lower alkyl or hydrogen; R3 is lower alkyl, hydroxy, or hydroge... | 02/25/1992 |
| 5063220 | Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine A pharmaceutical formulation suitable for parenteral (preferably intravenous) administration includes an effective amount of 1-diphenylmethyl-4-[(2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl]p iperazine and a suitable amount of an acid to generate a... | 11/05/1991 |
| 5057621 | 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives This invention covers a compound of the formula ##STR1## wherein R is hydrogen, lower alkyl or a pharmaceutically acceptable, non-toxic salt of a compound wherein R is hydrogen; X is hydrogen, halo, trifluoromethyl, lower alkyl or lower alkoxy, Y is ... | 10/15/1991 |
| 5049386 | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R1 and R2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R3, R4 and R | 09/17/1991 |
| 5043447 | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein: R1 is aryl, lower alkyl, cycloalkyl or hydrogen; R2 is aryl, lower alkyl or hydrogen; R3 is lower alkyl, hydroxy, or hydroge... | 08/27/1991 |
| 5010075 | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein: R1 is aryl, lower alkyl, cycloalkyl or hydrogen; R2 is aryl, lower alkyl or hydrogen; R3 is lower alkyl, hydroxy, or hydroge... | 04/23/1991 |
| 4997945 | Carbamate salts of 2-(2'-thienyl)alkylamines The carbamate salt of 2-(2'-thienyl)-alkylamines and particularly the ethylamine and its method of synthesis are disclosed. The carbamate salt of 2-(2'-thienyl)ethylamine is a stable, easily transportable crystalline material that can be converted to 2-(2... | 03/05/1991 |
| 4992467 | Treatment of autoimmune diseases with mycophenolic acid, and derivatives and formulations thereof The compounds and pharmaceutical compositions of Formula A, wherein Z is hydrogen or --C(O)R, Y is hydrogen or morpholinoethyl, and where R is lower alkyl or aryl, and the pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, ... | 02/12/1991 |
| 4973591 | Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine A pharmaceutical formulation suitable for parenteral (preferably intravenous) adminstration includes an effective amount of 1-diphenylmethyl-4-[(2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl]p iperazine and a suitable amount of an acid to generate a ... | 11/27/1990 |
| 4959387 | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis A method of treating rheumatoid arthritis which method comprises administering to a mammal in need of such treatment a therapeutically effective amount of a compound of the formula: ##STR1## and the pharmaceutically acceptable salts thereof, wherein:... | 09/25/1990 |
| 4957914 | 1,9-alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines 1,9-Alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines and the derivatives thereof, i.e., the compounds of Formula I: ##STR1## wherein: R is selected from the group consisting of: hydrogen, cyano, lower alkyl, lower alkenyl, and aralkyl; each of R | 09/18/1990 |
| 4952579 | Method of treating diseases by administering morpholino-ethylester of mycophenolic acid or derivatives thereof The compounds and pharmaceutical compositions of Formula A, wherein Z is hydrogen or --C(O)R, where R is lower alkyl or aryl, and the pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, anti-inflammatory agents, anti-tumor a... | 08/28/1990 |
| 4948793 | Treatment of autoimmune diseases with the morpholinoethyl ester of mycophenolic acid, and derivatives thereof The compounds and pharmaceutical compositions of Formula A, wherein Z is hydrogen or --C(O)R, Y is hydrogen or morpholinoethyl, and where R is lower alkyl or aryl, and the pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, ... | 08/14/1990 |
| 4946787 | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R1 and R2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R3, R4 and R | 08/07/1990 |
| 4935417 | Sustituted imidazolyl-alkyl-piperazine and -diazepine derivatives for treating cerebrovascular disease Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein: R1 is aryl, lower alkyl, cycloalkyl or hydrogen; R2 is aryl, lower alkyl or hydrogen; R3 lower alkyl, hydroxy, or hydrogen; ... | 06/19/1990 |
| 4935440 | 3-[ω-(3,5-Di-t-butyl-4-hydroxyphenyl)alkyl]pyrroles, and anti-inflammatory uses thereof 3-[ω-(3,5-Di-t-butyl-4-hydroxyphenyl)alkanoyl]-pyrroles and their de-oxy analogs, for example, 3-(3,5-di-t-butyl-4-hydroxybenzyl)pyrrole, 2-chloro-4-(3,5-di-t-butyl-4-hydroxybenzoyl)pyrrole, 3-(3,5-di-t-butyl-4-hydroxybenzoyl)pyrrole and 3-[2-(3,5-d... | 06/19/1990 |
| 4906756 | 2-(2-nitrovinyl)thiophene reduction and synthesis of thieno[3,2-c]pyridine derivatives An improved process for the reduction of 2-(2-nitrovinyl)thiophene to form 2-(2-thienyl)ethylamine employs a boron-containing reducing agent, preferably diborane. The 2-(2-thienyl)ethylamine produced by this process is advantageously converted to ticlopid... | 03/06/1990 |
| 4897355 | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R1 and R2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R3, R4 and R | 01/30/1990 |
